IRIS

Hexabromobenzene

CASRN 87-82-1

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (7 pp, 90 K) last updated: 03/31/1987

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Hepatic 2 x 10-3 Induced serum carboxylesterase activity, increased relative liver weight, increased liver porphyrins NOAEL : 2
mg/kg-day
1000 Low

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (7 pp, 90 K)
Not assessed under the IRIS Program.

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (7 pp, 90 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (7 pp, 90 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (7 pp, 90 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.